Burlingame, CA, United States of America

Lucy Estella Pill

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lucy Estella Pill: Innovator in Polysaccharide Conjugation Methods

Introduction

Lucy Estella Pill is a notable inventor based in Burlingame, California. She has made significant contributions to the field of biochemistry, particularly in the development of methods for preparing heteroaryl-containing compounds. Her innovative work has led to the filing of one patent, showcasing her expertise and dedication to advancing scientific knowledge.

Latest Patents

Lucy Estella Pill holds a patent for "Carrier-protein polysaccharide conjugation methods." This patent provides methods of preparing heteroaryl-containing compounds, wherein an azide-alkyne cycloaddition is accelerated in the presence of lauryldimethylamine oxide (LDAO). The disclosure further includes conjugates of polypeptides and antigens prepared using these methods, highlighting her innovative approach to bioconjugation.

Career Highlights

Lucy is currently employed at Vaxcyte, Inc., where she continues to apply her expertise in biochemistry and innovation. Her work at Vaxcyte focuses on developing novel vaccine technologies, contributing to advancements in public health.

Collaborations

Lucy has collaborated with esteemed colleagues such as Jeffery Fairman and Neeraj Kapoor. These partnerships reflect her commitment to teamwork and the sharing of knowledge in the scientific community.

Conclusion

Lucy Estella Pill is a pioneering inventor whose work in polysaccharide conjugation methods has the potential to impact various fields, including vaccine development. Her contributions to science and collaboration with other professionals underscore her importance in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…